Vistagen Therapeutics, Inc. - Common Stock, $0.001 par value per share (VTGN)

Historical Holders from Q2 2023 to Q1 2025

Symbol
VTGN on Nasdaq
CUSIP
92840H400
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
29.9M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
14.9M
Holdings value
$44M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
55
Number of buys
29
Number of sells
-18
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vistagen Therapeutics, Inc. - Common Stock, $0.001 par value per share (VTGN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOTECHNOLOGY VALUE FUND L P 9.97% $7.71M 3.08M BVF PARTNERS L P/IL Dec 31, 2024
Nantahala Capital Management, LLC 9.99% $7.09M 2.83M Nantahala Capital Management, LLC Sep 30, 2024
STEMPOINT CAPITAL LP 8.2% $5.82M 2.33M StemPoint Capital LP Dec 31, 2024
GREAT POINT PARTNERS LLC 6.88% $5.14M 2.06M Great Point Partners, LLC Dec 31, 2024

Institutional Holders of Vistagen Therapeutics, Inc. - Common Stock, $0.001 par value per share (VTGN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 27.7K $69.3K -$7.08K $2.50 2
2024 Q4 14.9M $44M -$1.1M $2.95 55
2024 Q3 14.6M $44.1M +$4.64M $3.01 47
2024 Q2 13M $45.4M -$5.79M $3.48 42
2024 Q1 14.6M $76.7M -$1.51M $5.28 41
2023 Q4 14.9M $76.1M +$50.5M $5.14 44
2023 Q3 3M $15.7M +$10.1M $5.24 34
2023 Q2 966K $1.81M +$1.81M $1.87 28